Comparison of diagnostic accuracy of QuantiFERON-TB Gold Plus and T-SPOT.TB in the diagnosis of active tuberculosis in febrile patients.

Lifan ZhangZhengrong YangXinmiao BaoHuimin MaQiping GeYueqiu ZhangQifei CaoMengqiu GaoXiaoqing Liu

Published in: Journal of evidence-based medicine (2022)

There was no significant difference between QFT-Plus and T-SPOT.TB for diagnosing ATB in febrile patients. QFT-Plus is prone to ITRS. The influencing factors including males, evidence of the previous TB, and use of immunosuppressant should be considered when interpreting positive results.

Keyphrases

mycobacterium tuberculosis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
urinary tract infection
antiretroviral therapy